Powles T, et al. A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO). ASCO-GU 2019, abstract 545.
Fase III-studie toont meerwaarde TIL aan bij gemetastaseerd melanoom
mrt 2023 | Dermato-oncologie